Neurocrine Biosciences, Inc. (NBIX)

Healthcare

$142.44

+0.84%

nightly snapshot · 10/11/2026

ALPHASCORE™ · B+ · Buy

ALPHASCORE

77

/ 100

B+

BUY

▲ 0 · 30D

KEY FUNDAMENTALS

P/E20.9

ROE14.7%

NET MARGIN16.7%

GROSS MARGIN98.2%

MKT CAP$14.48B

loading full analysis…

DAILY BRIEF

Neurocrine Biosciences, Inc. earns an AlphaScore of 77/100 in the Healthcare sector as of October 11, 2026. Fundamentals show a revenue growth of 21.45% and a gross margin of 98.18%. A notable strength is its near-complete gross margin coupled with robust, expanding revenue growth. A risk factor is its moderate momentum sub-score of 58/100. Evidence is limited to the provided financial metrics.

Written 11/10/2026, 00:43:41 UTC · Snapshot 11/10/2026